February 27, 2017 <\/p>\n
Obesity often leads to insulin resistance, a hallmark of type 2 diabetes. The anti-diabetic drug rosiglitazone counters insulin resistance in diabetic patients by targeting PPAR, a nuclear receptor that senses hormones and other molecules to help regulate the expression of genes. Rosiglitazone's ability to reverse insulin resistance is not fully understood, but prior work has implicated its effects on fat cells as a key driver of therapeutic success. <\/p>\n
Research led by Mitch Lazar at the Perelman School of Medicine at University of Pennsylvania examined how rosiglitazone treatment altered gene expression in fat cells from an obesity-prone strain of mice (B6 mice) that were fed a high-fat diet. <\/p>\n
In work published this week in the JCI, the researchers showed that although developing obesity was associated with marked changes in gene expression in the visceral fat of these mice, treatment with rosiglitazone had little effect on these changes. <\/p>\n
Rather, the drug affected subcutaneous fat, specifically increasing the expression of genes associated with brown fat, a metabolically-active type of fat characterized by the key gene Ucp1. <\/p>\n
An obesity-resistant strain, 129 mice, displayed elevated Ucp1 expression compared to B6 mice. A cross of B6 and 129 mice exhibited showed biased expression of Ucp1 genes derived from the 129 parent, indicating that Ucp1 may be defective in the obesity-prone B6 strain. In the B6\/129 crossed mice, rosiglitazone eliminated this bias and restored expression levels of the B6 parent-derived Ucp1 gene. <\/p>\n
These findings suggest that environmental changes, including drug therapies, may be able to reverse some genetic alterations that are associated with obesity. <\/p>\n
Explore further: Anti-aging gene identified as a promising therapeutic target for older melanoma patients <\/p>\n
More information: Raymond E. Soccio et al, Targeting PPAR in the epigenome rescues genetic metabolic defects in mice, Journal of Clinical Investigation (2017). DOI: 10.1172\/JCI91211<\/p>\n
Journal reference: Journal of Clinical Investigation <\/p>\n
Provided by: JCI Journals <\/p>\n
Scientists at The Wistar Institute have shown that an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression ... <\/p>\n
Ever imagined you could eat all the mouthwatering, festive food during winter holidays and never worry about an expanding waistline? <\/p>\n
Obesity is associated with reduced muscle mass and impaired metabolism. Epigenetic changes that affect the formation of new muscle cells may be a contributing factor, according to new research from Lund University, Sweden. <\/p>\n
Obesity is a risk factor for developing type 2 diabetes, yet not all obese humans develop the disease. In a new study, researchers from the Karolinska Institutet in Sweden and from the Institute of Health and Medical Research ... <\/p>\n
Good news for those who want to activate their brown fat (or BAT, brown adipose tissue) without having to be cold: New research, published in The FASEB Journal, suggests that a natural compound in mulberries, called \"rutin,\" ... <\/p>\n
Large-scale genetic studies have identified a number of variations in genes that increase an individual's susceptibility to obesity. <\/p>\n
An in-depth computational analysis of genetic variants implicated in both schizophrenia and rheumatoid arthritis by researchers at the University of Pittsburgh points to eight genes that may explain why susceptibility to ... <\/p>\n
A Mayo Clinic study has shown evidence linking the biology of aging with idiopathic pulmonary fibrosis, a disease that impairs lung function and causes shortness of breath, fatigue, declining quality of life, and, ultimately, ... <\/p>\n
From the double membrane enclosing the cell nucleus to the deep infolds of the mitochondria, each organelle in our cells has a distinctive silhouette that makes it ideally suited to do its job. How these shapes arise, however, ... <\/p>\n
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR\/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice. The unexpected findings, ... <\/p>\n
Researchers at the University of Illinois report they can alter blood cell development through the use of biomaterials designed to mimic characteristics of the bone marrow. <\/p>\n
In a study led by Barbara Driscoll, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, researchers demonstrate, for the first time that inhaled resveratrol treatments slow aging-related degenerative ... <\/p>\n
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more <\/p>\n
<\/p>\n
See more here: February 27, 2017 Obesity often leads to insulin resistance, a hallmark of type 2 diabetes. The anti-diabetic drug rosiglitazone counters insulin resistance in diabetic patients by targeting PPAR, a nuclear receptor that senses hormones and other molecules to help regulate the expression of genes. Rosiglitazone's ability to reverse insulin resistance is not fully understood, but prior work has implicated its effects on fat cells as a key driver of therapeutic success Continue reading
\nMedication improves obesity-associated gene expression in mice - Medical Xpress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"